CN Patent

CN101228151B — 4-甲基-n-[3-(4-甲基-咪唑-1-基)-5-三氟甲基-苯基]-3-(4-吡啶-3-基-嘧啶-2-基氨基)-苯甲酰胺的盐

Assigned to Novartis AG · Expires 2013-01-09 · 13y expired

What this patent protects

通过多种方法制备了4-甲基-N-[3-(4-甲基-咪唑-1-基)-5-三氟甲基-苯基]-3-(4-吡啶-3-基-嘧啶-2-基-氨基)-苯甲酰胺的盐。

USPTO Abstract

通过多种方法制备了4-甲基-N-[3-(4-甲基-咪唑-1-基)-5-三氟甲基-苯基]-3-(4-吡啶-3-基-嘧啶-2-基-氨基)-苯甲酰胺的盐。

Drugs covered by this patent

sonidegib-phosphate (SONIDEGIB PHOSPHATE)

Patent Metadata

Patent number: CN101228151B
Jurisdiction: CN
Classification: —
Expires: 2013-01-09
Drug substance claim: No
Drug product claim: No
Assignee: Novartis AG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.